Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Medical Director, MD COMP006@compasspathways.com


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Back

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Recruiting

Open to: ALL

Age: 18.0 - N/A

Sheffield London London Newcastle London Doncaster Nottingham Oxford Chertsey

Medical Conditions

Depression
Depressive Disorder, Treatment-Resistant

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Feb 2023 Mar 2025

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : COMP360 Psilocybin administered under supportive conditions

Intervention Arm Group : 1 mg COMP360 Psilocybin;10 mg COMP360 Psilocybin;25 mg COMP360 Psilocybin;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Sheffield Health and Social Care NHS Foundation Trust
    Sheffield
    S10 3TH
  • St. Pancras Clinical Research
    London
    EC2Y 8EA
  • Clerkenwell Health
    London
    W1G 8DR
  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust - Wolfson Research Centre
    Newcastle
    NE4 5PL
  • King's College London - Institute of Psychiatry, Psychology
    London
    SE5 8AF
  • Grounded Research Hub - Rotherham Doncaster & South Humber NHS Foundation Trust
    Doncaster
    DN4 8QN
  • University Of Nottingham/Nottinghamshire Healthcare Trust, Institute Of Mental Health
    Nottingham
    NG7 2TU
  • The Warneford Hospital- NIHR Clinical Research Facility
    Oxford
    OX3 7JX
  • Abraham Cowley Unit - Surrey and Borders Partnership NHS Foundation Trust
    Chertsey
    KT16 9AU

Medical Director, MD COMP006@compasspathways.com



The study is sponsored by COMPASS Pathways



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT05711940
Last updated 07 November 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top